Literature DB >> 24794528

Interneuron precursor transplants in adult hippocampus reverse psychosis-relevant features in a mouse model of hippocampal disinhibition.

Ahmed I Gilani1, Muhammad O Chohan2, Melis Inan3, Scott A Schobel2, Nashid H Chaudhury4, Samuel Paskewitz4, Nao Chuhma2, Sara Glickstein5, Robert J Merker4, Qing Xu6, Scott A Small7, Stewart A Anderson8, Margaret Elizabeth Ross9, Holly Moore10.   

Abstract

GABAergic interneuron hypofunction is hypothesized to underlie hippocampal dysfunction in schizophrenia. Here, we use the cyclin D2 knockout (Ccnd2(-/-)) mouse model to test potential links between hippocampal interneuron deficits and psychosis-relevant neurobehavioral phenotypes. Ccnd2(-/-) mice show cortical PV(+) interneuron reductions, prominently in hippocampus, associated with deficits in synaptic inhibition, increased in vivo spike activity of projection neurons, and increased in vivo basal metabolic activity (assessed with fMRI) in hippocampus. Ccnd2(-/-) mice show several neurophysiological and behavioral phenotypes that would be predicted to be produced by hippocampal disinhibition, including increased ventral tegmental area dopamine neuron population activity, behavioral hyperresponsiveness to amphetamine, and impairments in hippocampus-dependent cognition. Remarkably, transplantation of cells from the embryonic medial ganglionic eminence (the major origin of cerebral cortical interneurons) into the adult Ccnd2(-/-) caudoventral hippocampus reverses these psychosis-relevant phenotypes. Surviving neurons from these transplants are 97% GABAergic and widely distributed within the hippocampus. Up to 6 mo after the transplants, in vivo hippocampal metabolic activity is lowered, context-dependent learning and memory is improved, and dopamine neuron activity and the behavioral response to amphetamine are normalized. These findings establish functional links between hippocampal GABA interneuron deficits and psychosis-relevant dopaminergic and cognitive phenotypes, and support a rationale for targeting limbic cortical interneuron function in the prevention and treatment of schizophrenia.

Entities:  

Keywords:  contextual fear conditioning; functional magnetic resonance imaging; neural stem cell therapy; parvalbumin; temporal lobe-dependent cognition

Mesh:

Substances:

Year:  2014        PMID: 24794528      PMCID: PMC4034251          DOI: 10.1073/pnas.1316488111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission.

Authors:  Stan B Floresco; Anthony R West; Brian Ash; Holly Moore; Anthony A Grace
Journal:  Nat Neurosci       Date:  2003-09       Impact factor: 24.884

2.  Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus.

Authors:  Michael D Saxe; Fortunato Battaglia; Jing-Wen Wang; Gael Malleret; Denis J David; James E Monckton; A Denise R Garcia; Michael V Sofroniew; Eric R Kandel; Luca Santarelli; René Hen; Michael R Drew
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

3.  Stellate neurons mediate functional hyperemia in the cerebellar molecular layer.

Authors:  G Yang; J M Huard; A J Beitz; M E Ross; C Iadecola
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

Review 4.  GABAergic interneuron transplants to study development and treat disease.

Authors:  Jennifer A Tyson; Stewart A Anderson
Journal:  Trends Neurosci       Date:  2014-02-07       Impact factor: 13.837

5.  Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors.

Authors:  M E Bardgett; J D Henry
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

6.  Modality-specific retrograde amnesia of fear.

Authors:  J J Kim; M S Fanselow
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

7.  Amphetamine-induced hyperlocomotion in rats: Hippocampal modulation of the nucleus accumbens.

Authors:  Ilsun M White; Christopher Whitaker; Wesley White
Journal:  Hippocampus       Date:  2006       Impact factor: 3.899

8.  Brain anatomy in adults with velocardiofacial syndrome with and without schizophrenia: preliminary results of a structural magnetic resonance imaging study.

Authors:  Therese van Amelsvoort; Eileen Daly; Jayne Henry; Dene Robertson; Virginia Ng; Michael Owen; Kieran C Murphy; Declan G M Murphy
Journal:  Arch Gen Psychiatry       Date:  2004-11

Review 9.  A review of MRI findings in schizophrenia.

Authors:  M E Shenton; C C Dickey; M Frumin; R W McCarley
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

10.  The critical role of cyclin D2 in adult neurogenesis.

Authors:  Anna Kowalczyk; Robert K Filipkowski; Marcin Rylski; Grzegorz M Wilczynski; Filip A Konopacki; Jacek Jaworski; Maria A Ciemerych; Piotr Sicinski; Leszek Kaczmarek
Journal:  J Cell Biol       Date:  2004-10-25       Impact factor: 10.539

View more
  51 in total

Review 1.  Potential of GABA-ergic cell therapy for schizophrenia, neuropathic pain, and Alzheimer's and Parkinson's diseases.

Authors:  Ashok K Shetty; Adrian Bates
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

Review 2.  Using human brain imaging studies as a guide toward animal models of schizophrenia.

Authors:  S S Bolkan; F Carvalho Poyraz; C Kellendonk
Journal:  Neuroscience       Date:  2015-05-30       Impact factor: 3.590

Review 3.  The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia.

Authors:  Samuel M Cohen; Richard W Tsien; Donald C Goff; Michael M Halassa
Journal:  Schizophr Res       Date:  2015-01-09       Impact factor: 4.939

4.  Animal Models of Developmental Neuropathology in Schizophrenia.

Authors:  Nickole Kanyuch; Stewart Anderson
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

Review 5.  Cortical interneuron development: a tale of time and space.

Authors:  Jia Sheng Hu; Daniel Vogt; Magnus Sandberg; John L Rubenstein
Journal:  Development       Date:  2017-11-01       Impact factor: 6.868

Review 6.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 7.  Stem cell-based models and therapies: a key approach into schizophrenia treatment.

Authors:  Bagher Larijani; Peyvand Parhizkar Roudsari; Mahdieh Hadavandkhani; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Forough Azam Sayahpour; Fereshteh Mohamadi-Jahani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2021-01-02       Impact factor: 1.522

Review 8.  Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition.

Authors:  Tobias Bast; Marie Pezze; Stephanie McGarrity
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

9.  Loss of the neurodevelopmental gene Zswim6 alters striatal morphology and motor regulation.

Authors:  David J Tischfield; Dave K Saraswat; Andrew Furash; Stephen C Fowler; Marc V Fuccillo; Stewart A Anderson
Journal:  Neurobiol Dis       Date:  2017-04-19       Impact factor: 5.996

10.  G Protein-Gated K+ Channel Ablation in Forebrain Pyramidal Neurons Selectively Impairs Fear Learning.

Authors:  Nicole C Victoria; Ezequiel Marron Fernandez de Velasco; Olga Ostrovskaya; Stefania Metzger; Zhilian Xia; Lydia Kotecki; Michael A Benneyworth; Anastasia N Zink; Kirill A Martemyanov; Kevin Wickman
Journal:  Biol Psychiatry       Date:  2015-11-10       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.